PI Publications
- 2023Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. International Immunopharmacology. 121: 110437.
Gupta SK, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kaushal RK, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Hasan SK, Sandur SK, Hingorani L, Khattry N, Gota V
Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins. Translational Oncology. 35:101729.Dutta RP, Kumar R, Tembhare PR, Bagal B, Swain RK, Hasan SK
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax. J Exp Clin Cancer Res. 2023 Jul 29;42(1):186.Gaur T, Poddutoori R, Khare L, Bagal B, Rashmi S, Patkar N, Tembhare P, Pg S, Shetty D, Dutt A, Zhang Q, Konopleva M, Platzbeckar U, Gupta S, Samajdar S, Ramchandra M, Khattry N, Hasan SK
- 2022Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent. Cytometry B Clinical Cytometry. 102(6):462-470. PMID: 36346307.
Sriram H, Kunjachan F, Khanka T, Gawai S, Ghogale S, Deshpande N, Girase K, Patil J, Chatterjee G, Rajpal S, Patkar NV, Bagal B, Jain H, Sengar M, Hasan SK, Khattry N, Subramanian PG, Gujral S, Tembhare PR
- 2021Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-â/SMAD signaling. Breast Cancer Research and Treatment. 185(2):317-330 PMID: 33057846
Kumar R, Kuligina E, Sokolenko A, Siddiqui Q, Gardi N, Gupta S, Varma AK, Hasan SK (2021)
Improved protocol for plasma microRNA extraction and comparison of commercial kits. Biochemia Medica. 15;31(3):030705. PMID: 34658646Sriram H, Khanka T, Kedia S, Tyagi P, Ghogale S, Deshpande N, Chatterjee G, Rajpal S, Patkar NV, Subramanian PG, Gujral S, Hasan S, Tembhare PR
Editorial: Metabolic Rewiring in Leukemias. Front Oncol. 2021 Oct 8;11:775167.* Joint corresponding authorNoguera NI*, Hasan SK*, Ammatuna E, Venditti A.
- 2020miRNA-mRNA profiling reveals prognostic impact of SMC1A 4 expression in acute myeloid leukemia. Oncology Research. PMID: 32059753
Gadewal N, Kumar R, Aher S, Gardane A, Gaur T, Varma AK, Khattry N, Hasan SK
Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy. Medical Oncology. 37(5): 48. PMID: 32277283Bagal B, Kumar R, Gaur T, Talreja V, Bonda A, Patkar N, Shetty D, Kowtal P, Subramanian PG, Gupta S, Sarin R, Hasan SK (2020)
Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-â/SMAD signaling. Breast Cancer Research and Treatment. PMID: 33057846Kumar R, Kuligina E, Sokolenko A, Siddiqui Q, Gardi N, Gupta S, Varma AK, Hasan SK (2020)
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39. Breast Cancer Research and Treatment. 179(3): 731-742. PMID: 31754952Kuligina ES, Sokolenko AP, Bizin IV, Romanko AA, Zagorodnev KA, Anisimova MO, Krylova DD, Anisimova EI, Mantseva MA, Varma AK, Hasan SK, Ni VI, Koloskov AV, Suspitsin EN, Venina AR, Aleksakhina SN, Sokolova TN, Milanoviæ AM, Schürmann P, Prokofyeva DS, Bermisheva MA, Khusnutdinova EK, Bogdanova N, Dörk T, Imyanitov EN (2020)
Over-expression of BAALC and ERG is associated with poor outcome in acute myeloid leukemia. Hematological Oncology. 38(5):808-816. PMID: 32893896Hasan SK, Patkar NV, Rajamanickam D, Gokarn A, Lucena-Araujo AR, Tembhare P, Bagal B, Amare PK, Jain H, Gujral S, Sengar M, Subramanian PG, Khattry N
- 2019Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia.
Alfonso V, Iaccarino L, Ottone T, Cicconi L, Lavorgna S, Divona M, Cairoli R, Cristiano A, Ciardi C, Travaglini S, Falconi G, Hasan SK, Venditti A, Arcese W, Voso MT, Lo-Coco F. Leukemia. 2019 Jan 16.
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39. Breast Cancer Research and Treatment (2019). PMID: 31754952Kuligina ES, Sokolenko AP, Bizin IV, Romanko AA, Zagorodnev KA, Anisimova MO, Krylova DD, Anisimova EI, Mantseva MA, Varma AK, Hasan SK, Ni V, Koloskov AV, Suspitsin EN, Venina AR, Aleksakhina SN, Sokolova TN, Milanović AM, Schürmann P, Prokofyeva DS,
Utility of immunophenotypic measurable residual disease in adult acute myeloid leukemia –Real world context. Frontiers in Oncology (2019). 9:450. PMID: 31263671Patkar N, Kakirde C, Bhanshe P, Joshi S, Chaudhary S, Yajamanam B, Ghogale S, Deshpande N, Tembhare P, Kadechkar S, Kannan S, Shetty D, Gokarn A, Punatar S, Bonda A, Nayak L, Jain H, Bagal B, Menon H, Sengar M, Hasan KS, Khattry N, Gujral S, Subramani
- 2018Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia.Oncotarget. 2018;9(93):36613-36624.
Patkar N, Kodgule R, Kakirde C et. al
Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit.Khattry N, Laskar S, Sengar M, Rangarajan V, Shet T, Subramanian PG, Epari S, Bagal B, Goda JS, Agarwal A, Jain H, Tembhare P, Patkar N, Khanna N, Punatar S, Gokarn A, Shetty D, Jain H, Bonda A, Gota V, Hasan S, Kode J, Dutt S, Kulkarni S, Shetty N, Sable
Inhibition of novel GCN5-ATM axis restricts the onset of acquired drug resistance in leukemia.Int J Cancer. 2018 May 15;142(10):2175-2185Salunkhe S, Mishra SV, Nair J, Ghosh S, Choudhary N, Kaur E, Shah S, Patkar K, Anand D, Khattry N, Hasan SK, Dutt S
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India.Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018002Rabade N, Raval G, Chaudhary S, Subramanian PG, Kodgule R, Joshi S, Tembhare P, Hasan SK, Jain H, Sengar M, Narula G, Banavali S, Kadam PA, Shetty D, Gujral S, Patkar N.
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia.Patkar N, Kodgule R, Kakirde C, Raval G, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Khizer SH, Kannan S, Shetty D, Gokarn A, Punatkar S, Jain H, Bagal B, Menon H, Sengar M, Khattry N, Tembhare P, Subramanian P, Gujral S.
Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.Ottone T, Alfonso V, Iaccarino L, Hasan SK, Mancini M, Divona M, Lavorgna S, Cicconi L, Panetta P, Maurillo L, Del Principe MI, Irno Consalvo M, Franceschini L, Angelini DF, Battistini L, Guerrera G, De Bardi M, Fabiani E, Falconi G, Arcese W, Amadori S
Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.Iaccarino L, Ottone T, Hasan SK, Divona M, Cicconi L, Lavorgna S, Alfonso V, Basso G, Barragán E, Bocchia M, Rego EM, Grimwade D, Voso MT, Lo-Coco F. Leuk Lymphoma. 2018 May;59(5):1268-1270.
- 2017Studies of protein-protein interactions in Fanconi anemia pathway to unravel the DNA interstrand crosslink repair mechanism. Int J Biol Macromol. 2017;104:1338-1344
Siddiqui MQ, Rajpurohit YS, Thapa PS, Maurya GK, Banerjee K, Khan MA, Panda P, Hasan SK, Gadewal N, Misra HS, Varma AK
Structural and biophysical properties of h-FANCI ARM repeat protein. J Biomol Struct Dyn 2017;35:3032-3042 (*co-corresponding author)Siddiqui MQ, Choudhary RK, Thapa P, Kulkarni N, Rajpurohit YS, Misra HS, Gadewal N, Kumar S, Hasan SK*, Varma AK.
- 2015Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia.
Mancini M, Hasan SK, Ottone T, Lavorgna S, Ciardi C, Angelini DF, Agostini F, Venditti A, Lo-Coco F. J Mol Diagn. 2015 Mar;17(2):179-84.